Current Report Filing (8-k)
March 10 2023 - 11:41AM
Edgar (US Regulatory)
00-0000000 false 0001837739 0001837739 2023-03-09 2023-03-09 0001837739 claa:UnitsEachConsistingOfOneClassAOrdinaryShare0.0001ParValueAndOneFifthOfOneRedeemableWarrantMember 2023-03-09 2023-03-09 0001837739 us-gaap:CommonClassAMember 2023-03-09 2023-03-09 0001837739 claa:RedeemableWarrantsEachWarrantExercisableForOneClassAOrdinaryShareEachAtAnExercisePriceOf11.50PerShareMember 2023-03-09 2023-03-09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 9, 2023
COLONNADE ACQUISITION CORP. II
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Cayman Islands |
|
001-40184 |
|
N/A |
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
1400 Centrepark Blvd. Ste. 810
West Palm Beach, FL 33401
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (561) 712-7860
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fifth of one redeemable warrant |
|
CLAA.U |
|
The New York Stock Exchange |
Class A ordinary shares, par value $0.0001 per share |
|
CLAA |
|
The New York Stock Exchange |
Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share |
|
CLAA WS |
|
The New York Stock Exchange |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. |
Regulation FD Disclosure. |
On March 9, 2023, Colonnade Acquisition Corp. II (the “Company”) issued a press release announcing that it will redeem all of its outstanding Class A ordinary shares, effective as of March 13, 2023, because the Company will not be able to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
On March 9, 2023, the Company determined to cancel the extraordinary general meeting of shareholders, which had not been yet scheduled (the “Extension Meeting”), which was called for the purpose of amending the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination (the “Extension Amendment”).
2
As a result of the cancellation of the Extension Meeting, the Company will not complete the redemption of Class A ordinary shares submitted in connection with the Extension Amendment for the pro rata portion of the amounts held in the trust account established at the consummation of the Company’s initial public offering.
Item 9.01 |
Financial Statements and Exhibits. |
The following document is attached as an exhibit to this Current Report on Form 8-K.
Cautionary Note Regarding Forward-Looking Statements
Certain information contained in this Current Report on Form 8-K may be deemed to constitute forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements other than statements of historical fact are forward-looking statements, including, without limitation, the redemption of the Company’s public shares. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s latest Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
COLONNADE ACQUISITION CORP. II |
|
|
By: |
|
/s/ Remy W. Trafelet |
Name: |
|
Remy W. Trafelet |
Title: |
|
Chief Executive Officer |
|
|
(Principal Executive Officer and Principal Financial and Accounting Officer) |
Date: March 10, 2023
4
Colonnade Acquisition Co... (NYSE:CLAA)
Historical Stock Chart
From Oct 2024 to Nov 2024
Colonnade Acquisition Co... (NYSE:CLAA)
Historical Stock Chart
From Nov 2023 to Nov 2024